Test Price
1,800 AED✅ Home Collection Available
Ganglioside GD1b Antibody IgG Serology Test in UAE | 1800 AED
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139), fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection. Sample collected by DHA-licensed nurses between 8 AM – 11 PM, 7 days a week.
Clinical Guidance: Consultation with our General Practitioner, Dr. Ajay Singh (DHA License 36234132), for structured post-test clinical guidance and result correlation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731. All major UAE insurance networks accepted. Pre-approval arranged before collection.
Test Overview & Methodology
The Ganglioside GD1b Antibody IgG test detects circulating autoantibodies targeting the GD1b ganglioside, a glycolipid concentrated in peripheral nerves. This serological assay is essential for confirming immune-mediated neuropathies such as Guillain-Barré syndrome (GBS) and its sensory ataxic variants. Detection of GD1b IgG antibodies supports precise clinical stratification and treatment planning for patients presenting with acute or chronic neuropathy.
| Feature | DNA Labs UAE Assay (DHA-MOHAP Compliant) | Regional Reference Lab Alternatives |
|---|---|---|
| Methodology | Enzyme Immunoassay (EIA/ELISA) – gold-standard quantitative detection of anti-ganglioside antibodies | Western Blot or indirect immunofluorescence (semi-quantitative, lower throughput) |
| Diagnostic Specificity | ≥98% for GD1b-associated neuropathies (CLIA-validated protocol) | ~90–93%, with elevated risk of cross-reactivity and false positives |
| Turnaround Time | 2–3 weeks from sample receipt (batch optimized for quality control by the 7th of each month) | Often 4–6 weeks, reliant on overseas reference lab logistics |
| Home Collection | Included – VIP Mobile Phlebotomy with ISO cold-chain transport | Limited or not available for specialized serology |
Physician Insight & Safety Protocols
"A positive anti-GD1b IgG result is a critical serological clue in the diagnostic pathway for autoimmune neuropathies. It must be correlated with the patient's clinical presentation, reflex examination, and nerve conduction studies. Patients should always discuss findings with their primary neurologist for integrated management."
— Dr. Ajay Singh, General Practitioner (DHA License: 36234132)
Advisory Notice
⚠️ Medication Continuation Advisory: Do not discontinue, alter, or adjust any prescribed neurological medication without direct consultation with your treating physician. This diagnostic test provides serological data and does not replace comprehensive neurological evaluation or ongoing therapy management.
Exclusion Criteria & Safety Alerts
- Home Collection Exclusion: Patients under 18 years of age require in-clinic collection with parental or guardian supervision present per Federal Decree-Law No. 4 of 2016 on Medical Liability. Active febrile illness (temperature exceeding 38.5°C) or systemic infection on the day of collection necessitates rescheduling.
- Pharmacological Interference: High-dose intravenous immunoglobulin (IVIg) therapy or plasma exchange performed within the preceding 4 weeks may transiently suppress autoantibody titers, potentially yielding false-negative results. The referring physician must document any recent immunomodulatory therapy.
- Emergency Red Flags: If you experience sudden escalation of limb weakness, difficulty breathing, swallowing impairment, or acute visual changes, do not wait for test results. Seek immediate emergency medical attention by calling 998 for UAE ambulance services.
- Mandatory Pre-Collection Consent: A completed Test Send Out Consent Form (Form 35), signed by the ordering physician, is mandatory prior to sample collection. Overnight fasting (10–12 hours) is strongly preferred. Sample requirement: 2 mL serum (1 mL minimum) from a single SST tube, transported refrigerated or frozen via cold chain.
Patient FAQ & Clinical Guidance
1. What is the clinical significance of anti-GD1b IgG antibodies?
Anti-GD1b IgG antibodies are well-established serological biomarkers strongly associated with acute motor axonal neuropathy (AMAN) and sensory ataxic variants of Guillain-Barré syndrome. Their detection helps neurologists differentiate autoimmune neuropathies from other neurological disorders, enabling targeted immunotherapy and precise prognostic counseling.
2. How should I prepare for the GD1b antibody blood draw?
You must observe an overnight fast (plain water is permitted) and ensure the ordering physician has completed the mandatory Test Send Out Consent Form (Form 35) prior to the scheduled home collection or clinic visit. Our DHA-licensed phlebotomist will verify all documentation before proceeding with the venipuncture.
3. Why does the report take 2–3 weeks, and how are results delivered?
The GD1b IgG ELISA is a specialized, batch-processed serological assay requiring a minimum sample volume accumulated by the 7th of each month to maintain stringent quality control. Once the batch is processed, results undergo a rigorous two-step validation and are released securely via the DNA Labs UAE patient portal, with the option of a telephonic consultation for clinical correlation.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient health information, test results, and genomic or serological data are encrypted in transit and at rest, stored within secure UAE-based servers, and are never shared with third parties without explicit documented consent. Our data handling protocols are regularly audited to maintain alignment with the Dubai Health Authority (DHA) data governance standards.
Clinical & Logistical Metadata
| Test Name | Ganglioside GD1b Antibody IgG Serology Test |
| Price (AED) | 1,800.00 AED |
| Turnaround Time | 2–3 weeks (batch processed on monthly cycle) |
| Sample Type / Matrix | Serum (2 mL serum, 1 mL minimum from one SST tube) |
| Methodology Used | Enzyme Immunoassay (EIA / ELISA) |
| ICD-10-CM Code | G61.0 (Guillain-Barré syndrome) |
| LOINC Code | 53836-8 |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians